Drowsiness gabapentin

Gabapentin Modulate calcium channels and enhance GABA activity Loading dose Not recommended due to short half-life Maintenance dose 900-3600 mg/day in 3-4 divided doses (doses up to 1 0,000 mg/day have been tolerated) Half-life Not established 5-7 hours (proportional to creatinine clearance) Apparent volume of distribution 0.6-0.8 L/kg Protein binding less than 10% Primary elimination route Renal Drowsiness, sedation Peripheral edema, weight gain... 

The dose of gabapentin should be started at 600-900 mg/day in two or three doses per day. The usual effective dose is 900-4800 mg/day. Laboratory monitoring is not needed when prescribing gabapentin. It is well tolerated with the most common side effects being drowsiness and headache. 

The use of gabapentin has been reviewed (2). Its adverse effects are limited to neuropsychological disorders, namely dizzy spells, drowsiness, fatigue, and headache. The risk of interactions is also limited. 

Drowsiness, dizziness, fatigue, or ataxia are seen in 10-20% of patients who use gabapentin (SEDA-19, 70) (SEDA-20, 62) (10). Of 240 adults followed for about 1 year, only 4% discontinued treatment because of adverse events (SEDA-19, 70). Adverse effects... 

Pregabalin is another second-generation anticonvulsant that has recently obtained FDA approval for treatment of neurogenic pain, and several randomized placebo controlled studies have shown that this compound is efficacious in the treatment of painful diabetic neuropathy [32]. Doses between 300 and 600 mg/day have shown effect already apparent after 1 week of treatment. There are few clinically important drug interactions as there is no interference with the cytochrome 450 system. This compound requires minimal dose titration and seems easy to use. Side effects to gabapentin and pregabalin include drowsiness, dizziness and peripheral edema. 

Overdose and treatment acute oral overdoses of gabapentin up to 49 grams have been reported. In these cases, double vision, slurred speech, drowsiness, lethargy, and diarrhea were observed. All patients recovered with supportive care. Gabapentin can be removed by hemodialysis. Although hemodialysis was not performed in the few overdose cases reported, it may be indicated by the patient s chnical state or in patients with significant renal impairment. 

---